Edgar Voss

Title: Edgar Voss - Innovator in Biotin-Specific Monoclonal Antibodies

Introduction

Edgar Voss is a notable inventor based in Staufenberg, Germany. He is recognized for his contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the creation of a patent that holds significant potential in various applications.

Latest Patents

Edgar Voss holds a patent for a biotin-specific monoclonal antibody and its use. The invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment, the monoclonal antibody does not bind to a biotin moiety on a biotinylated molecule, where the biotin moiety is attached via the carbon atom of the carboxyl function of the valeric acid moiety of biotin. The patent also discloses a method for generating such an antibody. This monoclonal antibody is specifically useful in methods for measuring an analyte in a sample, utilizing a (strept)avidin/biotin pair to bind a biotinylated analyte-specific binding agent to a (strept)avidin-coated solid phase.

Career Highlights

Throughout his career, Edgar Voss has worked with prominent organizations, including Roche Diagnostics Operations, Inc. and the University Medical Center Göttingen. His experience in these institutions has contributed to his expertise in the field of monoclonal antibodies and diagnostics.

Collaborations

Edgar Voss has collaborated with notable colleagues, including Michael Gerg and Dieter Heindl. These partnerships have further enhanced his research and development efforts in biotechnology.

Conclusion

Edgar Voss is a distinguished inventor whose work on biotin-specific monoclonal antibodies has made a significant impact in the field of biotechnology. His innovative contributions continue to influence research and applications in diagnostics.